Principal Financial Group Inc Spring Works Therapeutics, Inc. Transaction History

Principal Financial Group Inc

$1.66 Trillion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 31, 2024	BUY	$32.04 - $42.76 $14.9 Million - $19.9 Million	464,903 Added 102.5%	918,445 $29.4 Million
Q2 2024 Jul 29, 2024	BUY	$36.06 - $47.62 $15.7 Million - $20.8 Million	436,598 Added 2576.71%	453,542 $17.1 Million
Q1 2024 Apr 29, 2024	BUY	$36.5 - $52.5 $30,076 - $43,260	824 Added 5.11%	16,944 $833,000
Q4 2023 Feb 07, 2024	BUY	$18.94 - $37.24 $23,315 - $45,842	1,231 Added 8.27%	16,120 $588,000
Q3 2023 Nov 02, 2023	SELL	$23.12 - $31.38 $10,588 - $14,372	-458 Reduced 2.98%	14,889 $344,000
Q2 2023 Aug 07, 2023	BUY	$23.15 - $32.71 $49,772 - $70,326	2,150 Added 16.29%	15,347 $402,000
Q1 2023 May 09, 2023	BUY	$24.97 - $34.05 $25,169 - $34,322	1,008 Added 8.27%	13,197 $339,000
Q4 2022 Feb 09, 2023	BUY	$21.73 - $28.72 $56,802 - $75,074	2,614 Added 27.3%	12,189 $317,000
Q3 2022 Nov 09, 2022	BUY	$24.1 - $39.66 $230,757 - $379,744	9,575 New	9,575 $273,000
Q2 2022 Aug 10, 2022	SELL	$18.36 - $60.07 $202,217 - $661,610	-11,014 Closed	0 $0
Q1 2022 May 09, 2022	BUY	$48.97 - $65.46 $8,520 - $11,390	174 Added 1.61%	11,014 $621,000
Q4 2021 Feb 09, 2022	SELL	$53.3 - $75.84 $278,918 - $396,870	-5,233 Reduced 32.56%	10,840 $672,000
Q3 2021 Nov 09, 2021	BUY	$62.66 - $88.26 $6,391 - $9,002	102 Added 0.64%	16,073 $1.02 Million
Q2 2021 Aug 10, 2021	BUY	$67.45 - $85.63 $86,943 - $110,377	1,289 Added 8.78%	15,971 $1.32 Million
Q1 2021 May 10, 2021	SELL	$65.1 - $93.59 $18,618 - $26,766	-286 Reduced 1.91%	14,682 $1.08 Million
Q4 2020 Feb 08, 2021	BUY	$48.36 - $77.92 $723,852 - $1.17 Million	14,968 New	14,968 $1.09 Million

Others Institutions Holding SWTX

# of Institutions

237

Shares Held

68.9M

Call Options Held

144K

Put Options Held

257K

Vanguard Group Inc Valley Forge, PA

6.71M
Shares

$239 Million
0.0% of portfolio
Black Rock Inc. New York, NY

5.62M
Shares

$200 Million
0.0% of portfolio
Deep Track Capital, LP Greenwich, CT

3.84M
Shares

$137 Million
4.54% of portfolio
Price T Rowe Associates Inc Baltimore, MD

3.52M
Shares

$125 Million
0.01% of portfolio
Boxer Capital, LLC San Diego, CA

3.42M
Shares

$122 Million
5.82% of portfolio

View Full List

About SpringWorks Therapeutics, Inc.

Ticker SWTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,401,100
Market Cap $2.22B
Description
SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...

More about SWTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Principal Financial Group Inc with notifications on news.

Account